Nivolumab--an effective second-line treatment for NSCLC

Nat Rev Clin Oncol. 2015 Dec;12(12):685. doi: 10.1038/nrclinonc.2015.184. Epub 2015 Oct 20.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Taxoids / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Taxoids